Abstract
Aim. To study the clinical and hemodynamic efficacy of monotherapy with ACE inhibitor perindopril or beta-blocker carvedilol in patients with chronic heart failure (CHF) due to dilated cardiomyopathy (DCMP) of various etiology. Material and methods. Patients (n=69) with DCMP of different etiology were included into the open randomized study. Idiopathic DCMP (IDCMP) was diagnosed in 26 patients and alcoholic cardiomyopathy (ACMP) - in 43 patients. Patients of IDCMP and ACMP groups were randomized for treatment with perindopril (groups 1 and 3, respectively) or carvedilol (groups 2 and 4, respectively). Follow-up was 6 months. End-diastolic and end-systolic left ventricular volume, stroke volume index, ejection fraction (EF) and exercise capacity were determined at baseline and in 2 and 6 months of treatment. Safety of the treatments was also assessed. Results. Group 1: the average CHF class (NYHA) decreased by 20.7% (p<0.01), EF increased by 18.2% (p<0.05). Group 2: the average CHF class decreased by 29.6% (p<0.01), EF increased by 18.2% (p<0.05). Group 3: the average CHF class decreased by 14.3% (p<0.01), EF increased by 19.6% (p<0.05). Group 4: the average CHF class decreased by 41.4% (p<0.001), EF increased by 32.8% (p<0.001). Conclusion. Monotherapy with carvedilol in patients with ACMP was more effective than this with perindopril. Long-term monotherapy with perindopril or carvedilol in patients with DCMP was well tolerated and safety.
Highlights
Некоронарогенные повреждения миокарда, сопровождающиеся дилатацией полостей сердца, или дилатационные кардиомиопатии (ДКМП), являются четвертой по частоте
В открытое рандомизированное исследование включены 69 пациентов с ДКМП различной этиологии: идиопатической ДКМП (ИДКМП; n=26) и алкогольной кардиомиопатией (АКМП; n=43).
Эффективность терапии ХСН при ДКМП карведилолом и периндоприлом ностью.
Summary
Некоронарогенные повреждения миокарда, сопровождающиеся дилатацией полостей сердца, или дилатационные кардиомиопатии (ДКМП), являются четвертой по частоте В открытое рандомизированное исследование включены 69 пациентов с ДКМП различной этиологии: идиопатической ДКМП (ИДКМП; n=26) и алкогольной кардиомиопатией (АКМП; n=43). Эффективность терапии ХСН при ДКМП карведилолом и периндоприлом ностью.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.